SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Pacira BioSciences Q1 EPS $0.530 Beats $0.320 Estimate, Sales $105.684M Beat $102.970M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.530 per share which beat the analyst consensus estimate of $0.320 by 65.63 percent. This is a 140.91 percent increase over earnings of $0.220 per share

Benzinga · 05/07/2020 12:27

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.530 per share which beat the analyst consensus estimate of $0.320 by 65.63 percent. This is a 140.91 percent increase over earnings of $0.220 per share from the same period last year. The company reported quarterly sales of $105.684 million which beat the analyst consensus estimate of $102.970 million by 2.64 percent. This is a 15.74 percent increase over sales of $91.313 million the same period last year.